Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer’s disease M Calvo-Rodriguez, SS Hou, AC Snyder, EK Kharitonova, AN Russ, ... Nature communications 11 (1), 2146, 2020 | 307 | 2020 |
The nucleus accumbens core is necessary to scale fear to degree of threat MH Ray, AN Russ, RA Walker, MA McDannald Journal of Neuroscience 40 (24), 4750-4760, 2020 | 43 | 2020 |
Reduced excitatory neuron activity and interneuron-type-specific deficits in a mouse model of Alzheimer’s disease M Algamal, AN Russ, MR Miller, SS Hou, M Maci, LP Munting, Q Zhao, ... Communications biology 5 (1), 1323, 2022 | 18 | 2022 |
Sleep restoration by optogenetic targeting of GABAergic neurons reprograms microglia and ameliorates pathological phenotypes in an Alzheimer’s disease model Q Zhao, M Maci, MR Miller, H Zhou, F Zhang, M Algamal, YF Lee, SS Hou, ... Molecular Neurodegeneration 18 (1), 93, 2023 | 10 | 2023 |
Optogenetic targeting of astrocytes restores slow brain rhythm function and slows Alzheimer’s disease pathology YF Lee, AN Russ, Q Zhao, SJ Perle, M Maci, MR Miller, SS Hou, ... Scientific reports 13 (1), 13075, 2023 | 9 | 2023 |
Neuronally derived Soluble Abeta evokes cell-wide astrocytic calcium dysregulation in absence of amyloid plaques in vivo P Kelly, MV Sanchez-Mico, SS Hou, S Whiteman, A Russ, E Hudry, ... Journal of Neuroscience 43 (26), 4926-4940, 2023 | 9 | 2023 |
Novel botanical therapeutic NB-02 effectively treats Alzheimer’s neuropathophysiology in an APP/PS1 mouse model YF Lee, L Lariviere, AN Russ, SZ Choi, BJ Bacskai, KV Kastanenka Eneuro 8 (3), 2021 | 6 | 2021 |
Hyperactive somatostatin interneurons near amyloid plaque and cell-type-specific firing deficits in a mouse model of Alzheimer’s disease M Algamal, AN Russ, MR Miller, SS Hou, M Maci, LP Munting, Q Zhao, ... bioRxiv, 2022.04. 27.489759, 2022 | 3 | 2022 |
Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer’s disease. Nat Commun 2020; 11 (1): 2146 M Calvo-Rodriguez, SS Hou, AC Snyder, EK Kharitonova, AN Russ, ... J Neurosci 34 (23), 7988-98, 2014 | 3 | 2014 |
Phase 1b/2a study evaluating the combination of MN-166 (ibudilast) and temozolomide in patients with newly diagnosed and recurrent glioblastoma (GBM). G Youssef, J Lathia, EQ Lee, UN Chukwueke, A Lauko, T Batchelor, ... Journal of Clinical Oncology 42 (16_suppl), 2016-2016, 2024 | 1 | 2024 |
Optogenetic Targeting of Astrocytes Restores Sleep-Dependent Brain Rhythm Function and Slows Alzheimer's Disease YF Lee, AN Russ, Q Zhao, M Maci, MR Miller, SS Hou, M Algamal, ... Available at SSRN 4079101, 0 | 1 | |
Slow wave activity disruptions and memory impairments in a mouse model of aging L Yu, AN Russ, M Algamal, MJ Abedin, Q Zhao, MR Miller, SJ Perle, ... Neurobiology of Aging 140, 12-21, 2024 | | 2024 |
A phase II, open label, single arm study of nivolumab for recurrent or progressive IDH mutant gliomas with prior exposure to alkylating agents. E Yim, L Donovan, A Bargo, L Nayak, Y Odia, ET Wong, K Pring, M Malig, ... Journal of Clinical Oncology 42 (16_suppl), 2056-2056, 2024 | | 2024 |
A PHASE 1B STUDY OF PEMBROLIZUMAB, IBRUTINIB AND RITUXIMAB IN RECURRENT/REFRACTORY (RR) PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) U Chukwueke, I Wright, A Muzikansky, A Russ, B Fontana, V Kats, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |